Long-Term Effectiveness of Lenacapavir in Heavily Treatment-Experienced People With HIV-1 in the US
CROI 2026 Feb 22-25 Denver
Onyema Ogbuagu1*, Andrea Marongiu2, Paul McDwyer2, Adanna Oragwu2, Hadas Dvory-Sobol2, Keith Dunn2, Adedotun Ogunbajo2T
1Yale School of Med., New Haven, CT, US. 2Gilead Sciences, Inc. Foster City, CA, US.
Current Afiliation: IQIVA, Durham, NC, US.
